Why Are Cancer Patients More Likely to Become Targets of Counterfeit Drugs?

[DengYueMed]

As global cancer incidence continues to rise, the market for anticancer drugs is also expanding rapidly. From targeted therapies and immunotherapy to CAR-T cell therapy and precision medicine, an increasing number of innovative treatments are transforming survival opportunities for cancer patients. However, against the backdrop of high treatment costs and unequal access to medical resources worldwide, counterfeit anticancer drugs are also spreading globally.
In recent years, regulatory authorities in multiple countries have uncovered large numbers of counterfeit oncology drug cases. These cases involve not only traditional chemotherapy medicines, but also PD-1 inhibitors, CAR-T-related therapies, targeted drugs, and popular GLP-1 weight-loss medications. Some counterfeit products even imitate complete packaging, anti-counterfeiting labels, and cold-chain documents, making them difficult for ordinary patients to identify.
Compared with patients suffering from common chronic diseases, cancer patients are often far more vulnerable to counterfeit drug scams — and the reasons go far beyond simply “expensive medicines.”



The “Time Pressure” of Cancer Treatment Makes Patients More Vulnerable

For many cancer patients, treatment time means survival opportunity.
Especially for patients with advanced-stage tumors, rapid disease progression often creates a desperate need to “find medicine immediately.” When hospitals temporarily face drug shortages, approval procedures take too long, or overseas innovative drugs are not yet officially available locally, so-called “special channels,” “overseas purchasing agents,” and “internal resources” begin to appear.
Scammers are highly skilled at exploiting this anxiety.
They often use phrases such as:

• “A newly launched overseas drug”
• “Exclusive hospital channel”
• “Much cheaper than official sources”
• “Already helping many cancer patients”
• “Only a few doses left”

For patients eager to begin treatment, such messages can be extremely persuasive. Many patients are not careless; rather, under the psychological pressure of “fear of missing a treatment opportunity,” they lower their guard regarding drug sources.
In the age of social media, counterfeit drug sellers can spread rapidly through patient chat groups, short-video platforms, forums, and private messaging apps, further increasing the risks.
High Prices and Strong Demand Make Oncology Drugs a Profitable Counterfeit Market

Cancer drugs have long been among the most profitable categories in the counterfeit pharmaceutical market.
Many innovative oncology therapies are extremely expensive, including targeted therapies, immunotherapies, and cell therapies, with some treatment courses costing hundreds of thousands of yuan. Meanwhile, significant price differences between countries have created complicated gray-market cross-border supply chains.
For counterfeiters, high prices mean enormous profits.
Compared with ordinary cold medicine, counterfeiting a single box of cancer drugs may generate dozens or even hundreds of times more profit. At the same time, patients often cannot identify fake medicines simply by appearance, creating more room for counterfeit circulation.
More dangerously, counterfeit drugs are not always merely “ineffective.” Some may contain incorrect ingredients, contaminants, or even no active pharmaceutical ingredients at all. For cancer patients undergoing treatment, this can lead not only to delayed therapy but also to severe side effects.
In some cases, patients who were originally responding well to treatment may lose their critical treatment window entirely after unknowingly using counterfeit medicines.
Rapid Innovation in Cancer Therapy Has Increased Information Gaps

In recent years, global oncology treatment has entered a period of rapid innovation.
From PD-1/PD-L1 immunotherapy and ADC drugs to bispecific antibodies, CAR-T therapies, and personalized cancer vaccines, new concepts continue to enter public discussion. However, most patients do not have professional medical knowledge and may struggle to fully understand these highly complex therapies.
This creates opportunities for illegal operators.
For example, some organizations exaggerate the effectiveness of CAR-T therapies or promote unapproved “cell therapy programs.” Others advertise so-called “latest overseas anticancer technologies” that have not actually received legitimate regulatory approval.
Some scams even involve forged laboratory reports, clinical data, and partnership documents with overseas hospitals, creating the illusion of advanced treatment.
Especially as cross-border medical services continue to expand, ordinary patients often find it difficult to determine:

• Whether a drug has truly been approved
• Whether a treatment institution is properly qualified
• Whether a product comes from a legitimate supply chain
• Whether a so-called “overseas innovative therapy” actually exists

This information imbalance has become one of the major drivers behind counterfeit drug problems. Online Drug Purchases and Gray Markets Further Increase Risks

The internet has made global pharmaceutical information spread faster, but it has also made counterfeit drug distribution easier.
Today, some patients purchase oncology medicines through social media, personal agents, anonymous websites, or private messaging apps. Certain websites closely resemble legitimate pharmacies and may even display professional English pages and “international certifications,” despite lacking legal authorization to sell medicines.
In addition, some counterfeit drugs avoid regulation through methods such as:

• Selling medicines outside original packaging
• Shipping products without labels
• Using unofficial cold-chain transportation

For biologic therapies that require strict temperature control, even genuine products may lose effectiveness if transported improperly.
As a result, drug safety involves more than simply distinguishing between genuine and counterfeit products. It also includes:

• Storage conditions
• Cold-chain transportation
• Batch traceability
• Compliant import procedures
• Medical institution qualifications

All of these factors directly affect patient safety.



DengYueMed: A Compliant Supply Chain Is More Important Than “Cheap Channels”

As counterfeit drug risks continue to escalate globally, more patients are beginning to realize that the real issue is not simply “being able to buy medicine,” but whether the medicine is authentic, safe, and traceable.
As a platform focused on innovative medicines and cross-border pharmaceutical services, DengYueMed continues to pay close attention to global drug safety, compliant oncology drug distribution, and patient medication risks.
In today’s increasingly complex international pharmaceutical supply chain environment, compliant platforms place greater emphasis on:

• Transparent drug sourcing
• Internationally compliant procurement
• Batch and traceability systems
• Cold-chain logistics management
• Legal cross-border supply chain verification

Especially for oncology therapies, CAR-T-related treatments, and high-value innovative medicines, compliance is not merely an industry standard — it is directly connected to patient safety.
DengYue believes that the future of the global pharmaceutical industry depends not only on innovation itself, but also on building a safer, more transparent, and more standardized international drug distribution system.
Conclusion

For cancer patients, the most important thing is not simply obtaining medicine itself, but obtaining treatment that is safe, authentic, and traceable.
The greatest danger of counterfeit drugs lies not only in financial fraud, but in the fact that they can take away valuable treatment opportunities.
In cancer treatment, time is critical, and the consequences of incorrect therapy are often irreversible.
Therefore, both patients and their families should remain cautious when facing so-called “miracle drugs,” “special overseas channels,” or unusually cheap innovative therapies. Whenever possible, they should seek medicines and treatment information through professional hospitals, licensed pharmacies, and compliant cross-border pharmaceutical platforms such as DengYueMed.
Healthcare that truly deserves trust should never be built on gray-market channels or misinformation, but on transparency, compliance, and patient safety.